← All trials
NCT06802185
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2025
- Primary completion
- Apr 12, 2025
- Completion date
- Apr 12, 2025
- First posted
- Jan 31, 2025
- Last posted
- Apr 23, 2025
- Enrollment
- 54
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Healeon Medical IncLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.